PBRM1 and neoplasm: The ccrcc2 group displayed the highest expression of the pro-angiogenic HIF-VEGF-VEGFR-pathway (VEGF-A, VEGFR-1, VEGFR-2, and HIF2A), particularly in tumours with a bi-allelic PBRM1 loss of function [115].